Your browser is no longer supported. Please, upgrade your browser.
Settings
CERC Cerecor Inc. daily Stock Chart
CERC [NASD]
Cerecor Inc.
Index- P/E- EPS (ttm)-1.25 Insider Own5.60% Shs Outstand45.71M Perf Week10.10%
Market Cap244.09M Forward P/E- EPS next Y-0.59 Insider Trans43.26% Shs Float31.49M Perf Month-2.73%
Income-45.30M PEG- EPS next Q-0.15 Inst Own54.00% Short Float1.19% Perf Quarter-5.99%
Sales19.30M P/S12.65 EPS this Y-259.90% Inst Trans7.04% Short Ratio3.57 Perf Half Y57.99%
Book/sh0.56 P/B9.54 EPS next Y1.70% ROA-65.90% Target Price9.67 Perf Year16.34%
Cash/sh0.35 P/C15.16 EPS next 5Y- ROE-218.90% 52W Range2.71 - 7.65 Perf YTD65.33%
Dividend- P/FCF- EPS past 5Y4.60% ROI-108.20% 52W High-30.20% Beta2.13
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin55.50% 52W Low97.05% ATR0.38
Employees64 Current Ratio1.00 Sales Q/Q20.00% Oper. Margin- RSI (14)54.48 Volatility9.12% 7.29%
OptionableYes Debt/Eq0.67 EPS Q/Q-45.60% Profit Margin- Rel Volume1.20 Prev Close5.71
ShortableYes LT Debt/Eq0.62 EarningsMay 10 BMO Payout- Avg Volume105.41K Price5.34
Recom1.70 SMA205.20% SMA501.26% SMA20012.56% Volume126,319 Change-6.48%
Apr-09-19Initiated Maxim Group Buy $10
Apr-01-19Initiated H.C. Wainwright Buy $11
Dec-20-18Initiated Ladenburg Thalmann Buy
Dec-12-16Downgrade Rodman & Renshaw Buy → Neutral $4 → $1
Apr-13-16Initiated Rodman & Renshaw Buy $15
Dec-09-15Initiated Laidlaw Buy $10
Jun-12-19 04:05PM  Cerecor Appoints Keith Schmidt to its Board of Directors GlobeNewswire
Jun-11-19 01:00PM  Cerecor Set to Join Russell 3000® Index GlobeNewswire +5.42%
May-13-19 02:00PM  CERC: Completion of Phase 1 Trial of CERC-801 Zacks Small Cap Research
May-09-19 04:05PM  Cerecor Reports First Quarter 2019 Results GlobeNewswire -5.86%
Apr-29-19 10:38AM  Introducing Cerecor (NASDAQ:CERC), A Stock That Climbed 42% In The Last Three Years Simply Wall St.
06:30AM  Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers GlobeNewswire
Apr-17-19 10:15AM  CERC: Positive Results for Phase 1 Trial of CERC-301 Zacks Small Cap Research
Apr-15-19 06:30AM  Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH) ACCESSWIRE
Apr-11-19 06:30AM  Cerecor Announces Leadership Changes ACCESSWIRE
Mar-26-19 10:30AM  CERC: Multiple Data Readouts in 2019; Commercial Unit Continues Growth Zacks Small Cap Research
Mar-18-19 04:05PM  Cerecor Reports Fourth Quarter and Full Year 2018 Results ACCESSWIRE
Mar-06-19 06:05AM  Cerecor Increases Previously Announced Bought Deal of Common Stock to $10 Million ACCESSWIRE
Mar-05-19 05:30PM  Cerecor Announces $8 Million Bought Deal Offering ACCESSWIRE -20.20%
Feb-22-19 10:11AM  Do Insiders Own Lots Of Shares In Cerecor Inc. (NASDAQ:CERC)? Simply Wall St.
Feb-19-19 08:27AM  Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency GlobeNewswire
Feb-15-19 06:30AM  Cerecor Announces CERC-301 Granted U.S. Patent GlobeNewswire +13.00%
Jan-28-19 06:30AM  Cerecor Announces U.S. Headquarters Move Into Pharmaceutical Corridor of Rockville, Maryland GlobeNewswire
Jan-22-19 06:30AM  FDA Accepts IND Application for Cerecors Investigational Drug CERC-801 for the treatment of PGM1 Deficiency GlobeNewswire
Jan-16-19 06:30AM  FDA Grants Cerecors Three Substrate Replacement Therapies Orphan Drug Designation GlobeNewswire +15.74%
Dec-13-18 07:00AM  Antares Pharma Announces the Appointment of Peter S. Greenleaf to Companys Board of Directors GlobeNewswire
Nov-26-18 12:00PM  CERC: Unveils Rare Pediatric Disease Programs Zacks Small Cap Research
Nov-22-18 02:13PM  What Kind Of Share Price Volatility Should You Expect For Cerecor Inc (NASDAQ:CERC)? Simply Wall St.
Nov-21-18 08:55AM  Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-13-18 07:00AM  Cerecor Reports Third Quarter 2018 Results GlobeNewswire
Oct-31-18 04:00PM  Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation GlobeNewswire +8.47%
Oct-30-18 04:00PM  Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism GlobeNewswire
Oct-02-18 09:20AM  CERC: Transformation Continues with Purchase of Ichorion Therapeutics, Inc Zacks Small Cap Research -6.22%
Sep-26-18 01:00PM  Cerecor to Participate in Upcoming Healthcare Conferences GlobeNewswire
11:29AM  Baltimore's Cerecor buys New York biotech for $26.6M in stock American City Business Journals
Sep-25-18 06:30AM  Cerecor to Acquire Ichorion Therapeutics GlobeNewswire
Aug-31-18 02:46PM  Penny Stocks to Buy Using Technical Analysis for September 2018 Investopedia
07:00AM  Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-15-18 01:15PM  CERC: Phase 1 Trial of CERC-301 in nOH Underway Zacks Small Cap Research
Aug-09-18 06:30AM  Cerecor Reports Second Quarter 2018 Financial Results GlobeNewswire -7.63%
Aug-01-18 06:30AM  Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinsons Disease GlobeNewswire
Jul-31-18 01:37PM  Penny Stocks to Watch for August 2018 Investopedia
Jul-16-18 06:00AM  Cerecor Announces Expansion of Leadership Team GlobeNewswire
Jul-12-18 02:00AM  [$$] The drug pricing playbook: how pharma companies keep costs high Financial Times
May-22-18 08:29AM  BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board GlobeNewswire
May-19-18 10:02AM  May Top Undervalued Stock Simply Wall St.
May-17-18 09:55AM  CERC: Converting into a Fully Independent Healthcare Company Zacks Small Cap Research
08:01AM  BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business GlobeNewswire
May-11-18 08:15AM  Cerecor Reports First Quarter 2018 Financial Results GlobeNewswire -10.03%
May-10-18 07:40AM  Wired News CymaBay Therapeutics Starts Phase-2b Clinical Trials of Seladelpar for Treatment of Patients with Non-Alcoholic Steatohepatitis ACCESSWIRE
Apr-09-18 08:00AM  Cerecor Appoints Simon Pedder to its Board of Directors Marketwired -5.31%
Apr-02-18 08:00AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017 Marketwired
Mar-28-18 10:02AM  Flavor Of The Month: inTEST And More Simply Wall St. -7.78%
08:00AM  Cerecor Appoints Peter Greenleaf as Chief Executive Officer Marketwired
Mar-07-18 03:15PM  Have Investors Already Priced In Cerecor Incs (NASDAQ:CERC) Growth? Simply Wall St. +9.90%
Feb-12-18 05:06PM  Cerecor Incs (NASDAQ:CERC) Insiders Recently Ramped Up Their Holdings Should You? Simply Wall St. +9.84%
09:07AM  Cerecor to Acquire Avadel Pharmaceuticals' Pediatric Assets Marketwired
Jan-10-18 07:52PM  What Does Cerecor Incs (NASDAQ:CERC) Ownership Structure Look Like? Simply Wall St. -11.46%
Dec-26-17 09:00AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube +9.57%
Dec-25-17 05:45PM  What Are The Drivers Of Cerecor Incs (NASDAQ:CERC) Risks? Simply Wall St.
Dec-18-17 09:05AM  Can Cerecor Inc (NASDAQ:CERC) Continue To Outperform Its Industry? Simply Wall St. +11.86%
Dec-08-17 10:33AM  Should You Buy Cerecor Inc (CERC) At This PE Ratio? Simply Wall St.
Nov-29-17 07:30AM  This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice ACCESSWIRE +36.36%
Nov-21-17 07:40AM  Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals ACCESSWIRE
Nov-20-17 12:45PM  Is It The Right Time To Buy Cerecor Inc (CERC)? Simply Wall St.
Nov-17-17 10:35AM  Baltimore pharmaceutical company acquiring North Carolina firm for at least $27 million American City Business Journals
08:30AM  Cerecor Announces Leadership Changes Marketwired
08:15AM  Cerecor Acquires TRx Pharmaceuticals Marketwired
08:02AM  Best Undervalued Stock Picks Simply Wall St.
Nov-09-17 11:45AM  CERC: With An Infusion of Non-dilutive Capital, Cerecor Ready to Move the Pipeline Forward Zacks Small Cap Research
Nov-06-17 09:32AM  What does Cerecor Incs (CERC) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
08:15AM  Cerecor Inc. Reports Third Quarter 2017 Financial Results Marketwired
Oct-18-17 08:15AM  Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement Marketwired
Oct-05-17 05:46PM  Dilution Ahead For Cerecor Inc (CERC) Shareholders? Simply Wall St.
Aug-17-17 11:15AM  CERC: Sells CERC-501 for $25 Million; Company Currently Trading Below Cash Value Zacks Small Cap Research
Aug-16-17 01:22PM  What Shareholders Should Make of the Johnson & Johnson-Cerecor Situation GuruFocus.com
10:44AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-14-17 08:04AM  Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Marketwired
08:02AM  Cerecor Inc. Reports Second Quarter 2017 Financial Results Marketwired
08:00AM  Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc. Marketwired
May-30-17 08:30AM  Cerecor to present at the American Society for Clinical Psychopharmacology Conference Marketwired
May-15-17 08:30AM  Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors Marketwired
May-10-17 02:00PM  CERC: Encouraging Results from Proof-of-Concept Study of CERC-501 in MDD Zacks Small Cap Research
May-09-17 08:30AM  Cerecor Inc. Reports First Quarter 2017 Financial Results Marketwired
May-01-17 08:30AM  Cerecor Reports Encouraging Topline Data from a NIH Sponsored Proof-of-Concept Trial of CERC-501 in Treatment-Resistant Depression Marketwired
Apr-28-17 08:30AM  Cerecor Inc. Closes $5.0 Million Private Placement Marketwired
Mar-21-17 03:00PM  CERC: Ready to Move Ahead With Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research
Mar-18-17 01:04PM  CERECOR INC. Financials
Mar-14-17 01:22PM  CERECOR INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:37AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Marketwired
Mar-13-17 05:25PM  CERECOR INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-02-17 04:39PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Feb-16-17 01:34PM  These 5 Stocks Under $10 Could Explode Higher
Feb-07-17 09:32AM  Cerecor Engages SunTrust Robinson Humphrey to Assist with Review of Strategic Alternatives Marketwired
Jan-30-17 04:34PM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-27-17 04:26PM  CERECOR INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
04:20PM  Cerecor Announces At-the-Market Equity Offering Program Marketwired
Jan-20-17 04:05PM  CERECOR INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
Dec-12-16 07:12AM  Cerecor downgraded by Rodman & Renshaw
Dec-06-16 04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) Investopedia
04:09PM  Cerecor Nicotine Withdrawal Drug Fails Study (CERC) at Investopedia
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining Insider Monkey
01:06PM  Cerecor Inc (CERC)s Trial Failure Isnt All Bad, Heres The Silver Lining at Insider Monkey
Dec-05-16 03:00PM  CERC: CERC-501 Not Successful in Nicotine Withdrawal; Preparing for Phase 2/3 Study of CERC-501 in MDD Zacks Small Cap Research
11:51AM  Ciao, euro! Global markets gird for the next wave of global populism at MarketWatch
08:16AM  CERECOR INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-406 for the treatment of Parkinson's disease; CERC-425, an orally active small molecule; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and CERC-913, a protide nucleotide for the treatment of mitochondrial disorder. It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Calias PericlesChief Scientific OfficerJun 10Buy2.854,54912,95349,549Jun 11 07:36 PM
Phillips Matthew VChief Commercial OfficerJun 10Buy2.855231,4891,020Jun 11 09:04 PM
Miller Joseph MChief Financial OfficerJun 10Buy2.851,1793,35746,179Jun 11 08:47 PM
Harrell James Archie JrExec. VP, Mktg & External CommJun 10Buy2.854,39812,5238,554Jun 11 07:51 PM
ARMISTICE CAPITAL, LLCDirectorJun 07Buy4.8810,00048,750300,000Jun 11 06:01 PM
ARMISTICE CAPITAL, LLCDirectorJun 05Buy4.975,00024,85018,429,285Jun 05 05:52 PM
ARMISTICE CAPITAL, LLCDirectorJun 03Buy4.7310,00047,30018,424,285Jun 05 05:52 PM
ARMISTICE CAPITAL, LLCDirectorMay 31Buy4.9113,80067,75818,414,285May 31 04:50 PM
ARMISTICE CAPITAL, LLCDirectorMay 30Buy4.6418,20084,44818,400,485May 31 04:50 PM
ARMISTICE CAPITAL, LLCDirectorMay 29Buy4.6319,00087,97018,382,285May 31 04:50 PM
ARMISTICE CAPITAL, LLCDirectorMay 28Buy4.923,50017,22018,363,285May 28 06:13 PM
ARMISTICE CAPITAL, LLCDirectorMay 24Buy5.0111,40057,11418,359,785May 28 06:13 PM
ARMISTICE CAPITAL, LLCDirectorMay 23Buy5.0514,10071,20518,348,385May 28 06:13 PM
ARMISTICE CAPITAL, LLCDirectorMay 17Buy5.331,7989,58318,334,285May 20 06:26 PM
ARMISTICE CAPITAL, LLCDirectorMay 16Buy5.158,20242,24018,332,487May 20 06:26 PM
Pedder SimonExecutive Chairman of the BdMay 14Buy5.066,00030,3366,000May 16 04:19 PM
ARMISTICE CAPITAL, LLCDirectorMay 14Buy5.274,90925,87018,324,285May 14 07:32 PM
ARMISTICE CAPITAL, LLCDirectorMay 13Buy4.8512,58761,04718,319,376May 14 07:32 PM
ARMISTICE CAPITAL, LLCDirectorMay 10Buy4.952,50412,39518,306,789May 14 07:32 PM
ARMISTICE CAPITAL, LLCDirectorMar 27Buy5.4810,00054,80018,304,285Mar 27 06:43 PM
ARMISTICE CAPITAL, LLCDirectorMar 26Buy5.5210,00055,200290,000Mar 27 06:43 PM
ARMISTICE CAPITAL, LLCDirectorMar 26Buy5.4816,23888,98418,294,285Mar 27 06:43 PM
ARMISTICE CAPITAL, LLCDirectorMar 25Buy5.4013,76274,31518,278,047Mar 27 06:43 PM
ARMISTICE CAPITAL, LLCDirectorMar 08Buy5.464,00021,83518,264,285Mar 08 06:33 PM
ARMISTICE CAPITAL, LLCDirectorMar 07Buy5.476,00032,80718,260,285Mar 08 06:33 PM
ARMISTICE CAPITAL, LLCDirectorMar 06Buy5.50239,0001,314,500280,000Mar 08 06:33 PM
ARMISTICE CAPITAL, LLCDirectorMar 06Buy5.50125,486690,17218,254,285Mar 08 06:33 PM
ARMISTICE CAPITAL, LLCDirectorJan 11Buy3.9012,65149,31318,169,799Jan 11 06:04 PM
ARMISTICE CAPITAL, LLCDirectorJan 10Buy3.708002,95818,157,148Jan 11 06:04 PM
ARMISTICE CAPITAL, LLCDirectorJan 09Buy3.795452,06418,156,348Jan 11 06:04 PM
ARMISTICE CAPITAL, LLCDirectorJan 08Buy3.705001,84918,155,803Jan 08 05:49 PM
ARMISTICE CAPITAL, LLCDirectorJan 07Buy3.656,50423,74518,155,303Jan 08 05:49 PM
ARMISTICE CAPITAL, LLCDirectorJan 04Buy3.4220,00068,32018,148,799Jan 08 05:49 PM
ARMISTICE CAPITAL, LLCDirectorDec 31Buy3.1812,30039,08118,128,799Dec 31 05:47 PM
ARMISTICE CAPITAL, LLCDirectorDec 28Buy3.1226,49982,67718,116,499Dec 31 05:47 PM
ARMISTICE CAPITAL, LLCDirectorDec 18Buy3.317,03023,26218,090,000Dec 18 05:23 PM
ARMISTICE CAPITAL, LLCDirectorDec 17Buy3.2614,93848,70118,082,970Dec 18 05:23 PM
ARMISTICE CAPITAL, LLCDirectorDec 14Buy3.3328,03293,44518,068,032Dec 18 05:23 PM
Harrell James Archie JrExec. VP, Mktg & External CommDec 10Buy2.854,15611,8344,156Dec 11 05:31 PM
Phillips Matthew VChief Commercial OfficerDec 10Buy2.854971,415497Dec 11 05:22 PM
ARMISTICE CAPITAL, LLCDirectorDec 10Buy3.3613,81546,39718,040,000Dec 10 06:02 PM
ARMISTICE CAPITAL, LLCDirectorDec 07Buy3.446,18521,25418,026,185Dec 10 06:02 PM
ARMISTICE CAPITAL, LLCDirectorDec 06Buy3.4416,40056,49418,020,000Dec 10 06:02 PM
ARMISTICE CAPITAL, LLCDirectorDec 04Buy3.402,2007,48818,003,600Dec 04 06:19 PM
ARMISTICE CAPITAL, LLCDirectorDec 03Buy3.5019,49568,31418,001,400Dec 04 06:19 PM
ARMISTICE CAPITAL, LLCDirectorNov 30Buy3.504,10214,35117,981,905Dec 04 06:19 PM
ARMISTICE CAPITAL, LLC10% OwnerNov 29Buy3.4817,80361,94617,977,803Nov 29 06:27 PM
ARMISTICE CAPITAL, LLC10% OwnerNov 28Buy3.5233,346117,48817,960,000Nov 29 06:27 PM
ARMISTICE CAPITAL, LLC10% OwnerNov 27Buy3.5126,65493,43017,926,654Nov 29 06:27 PM
ARMISTICE CAPITAL, LLCDirectorNov 26Buy3.5835,000125,38117,900,000Nov 26 05:58 PM
ARMISTICE CAPITAL, LLCDirectorNov 23Buy3.645,00018,22217,865,000Nov 26 05:58 PM
ARMISTICE CAPITAL, LLCDirectorNov 21Buy3.5810,00035,80517,860,000Nov 26 05:58 PM
ARMISTICE CAPITAL, LLCDirectorNov 20Buy3.6114,00050,51217,850,000Nov 20 06:03 PM
ARMISTICE CAPITAL, LLCDirectorNov 19Buy3.5623,80084,74617,836,000Nov 20 06:03 PM
ARMISTICE CAPITAL, LLCDirectorNov 16Buy3.7211,30042,03517,812,200Nov 20 06:03 PM
ARMISTICE CAPITAL, LLCDirectorNov 15Buy3.8011,21842,62117,800,900Nov 15 05:35 PM
ARMISTICE CAPITAL, LLCDirectorNov 14Buy3.814,80918,31217,789,682Nov 15 05:35 PM
ARMISTICE CAPITAL, LLCDirectorNov 13Buy3.9015,28759,64517,784,873Nov 15 05:35 PM
ARMISTICE CAPITAL, LLCDirectorOct 31Buy3.914,58617,92217,769,586Nov 01 06:10 PM
ARMISTICE CAPITAL, LLCDirectorOct 30Buy3.971,4005,55917,765,000Nov 01 06:10 PM
ARMISTICE CAPITAL, LLCDirectorOct 29Buy3.9433,292131,04717,763,600Oct 29 05:36 PM
ARMISTICE CAPITAL, LLCDirectorOct 26Buy3.9455,899220,19517,730,308Oct 29 05:36 PM
ARMISTICE CAPITAL, LLCDirectorOct 25Buy3.9918,60974,27017,674,409Oct 29 05:36 PM
ARMISTICE CAPITAL, LLCDirectorOct 24Buy4.0683,800340,41017,655,800Oct 25 10:22 AM
ARMISTICE CAPITAL, LLCDirectorOct 23Buy4.2022,00092,36517,572,000Oct 25 10:22 AM
ARMISTICE CAPITAL, LLCDirectorOct 22Buy4.3120,00086,29017,550,000Oct 25 10:22 AM
ARMISTICE CAPITAL, LLCDirectorOct 09Buy4.376,50028,39317,530,000Oct 09 05:23 PM
ARMISTICE CAPITAL, LLCDirectorOct 08Buy4.3319,58884,78517,523,500Oct 09 05:23 PM
ARMISTICE CAPITAL, LLCDirectorOct 05Buy4.321,4976,47117,503,912Oct 09 05:23 PM
ARMISTICE CAPITAL, LLCDirectorOct 04Buy4.352,0158,75517,502,415Oct 09 05:23 PM
ARMISTICE CAPITAL, LLCDirectorSep 27Buy4.716,47330,46117,500,400Sep 27 05:15 PM
ARMISTICE CAPITAL, LLCDirectorSep 26Buy4.634,63121,41917,493,927Sep 27 05:15 PM
ARMISTICE CAPITAL, LLCDirectorSep 25Buy4.609,29642,74917,489,296Sep 27 05:15 PM
ARMISTICE CAPITAL, LLCDirectorAug 17Buy3.911,000,0003,910,00017,480,000Aug 20 05:03 PM
Jones Randal10% OwnerAug 13Option Exercise3.201,2704,0641,270Oct 18 05:10 PM
Jones Randal10% OwnerAug 13Sale3.981,2705,0550Oct 18 05:10 PM
ARMISTICE CAPITAL, LLCDirectorJul 31Buy4.216552,75716,480,000Aug 01 05:04 PM
ARMISTICE CAPITAL, LLCDirectorJul 30Buy4.262,2009,37716,479,345Aug 01 05:04 PM
ARMISTICE CAPITAL, LLCDirectorJul 27Buy4.4317,14575,87116,477,145Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 26Buy4.484,08118,30116,460,000Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 25Buy4.347,70033,40416,455,919Jul 27 05:25 PM
ARMISTICE CAPITAL, LLCDirectorJul 18Buy4.352,50010,86616,448,219Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 17Buy4.309,71941,77416,445,719Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 16Buy4.2617,80075,76516,436,000Jul 18 05:24 PM
ARMISTICE CAPITAL, LLCDirectorJul 02Buy4.283,80016,27616,418,200Jul 02 05:54 PM
ARMISTICE CAPITAL, LLCDirectorJun 28Buy4.0614,40058,48216,414,400Jul 02 05:54 PM